echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Xianju Pharmaceutical's drospirenone and ethinylestradiol tablets (Ⅱ) domestic production drug registration application approved

    Xianju Pharmaceutical's drospirenone and ethinylestradiol tablets (Ⅱ) domestic production drug registration application approved

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 12, Xianju Pharmaceutical issued an announcement stating that it had recently received a notification of acceptance of registration for domestic production of drospirenone and ethinyl estradiol tablets (II) issued by the State Drug Administration.


    Drospirenone and ethinyl estradiol tablets (II) are compound preparations containing two active ingredients, drospirenone and ethinyl estradiol.


    Indications: 1.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.